{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:22:47Z","timestamp":1777357367335,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vph.2020.106810","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T13:10:47Z","timestamp":1604927447000},"page":"106810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses"],"prefix":"10.1016","volume":"136","author":[{"given":"Maria del Carmen","family":"Gonzalez-Montelongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Fountain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2020.106810_bb0005","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/j.1476-5381.1995.tb15060.x","article-title":"Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226","volume":"116","author":"Abounader","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2020.106810_bb0010","first-page":"S1","article-title":"Overview","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.1988.tb11662.x","article-title":"Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries","volume":"95","author":"Andriantsitohaina","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0020","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1073\/pnas.94.23.12661","article-title":"Localization of neuropeptide Y Y1 receptors in cerebral blood vessels","volume":"94","author":"Bao","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2020.106810_bb0025","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/S0021-9258(17)42015-1","article-title":"Selective activation of phospholipase C by recombinant G-protein alpha- and beta gamma-subunits","volume":"269","author":"Boyer","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2020.106810_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.vph.2020.106810_bb0035","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1476-5381.1996.tb15560.x","article-title":"Effects of neuropeptide Y on L-type calcium current in Guinea-pig ventricular myocytes","volume":"118","author":"Bryant","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0169-328X(97)00302-1","article-title":"Distribution of a novel hypothalamic neuropeptide Y receptor gene and it\u2019s absence in rat","volume":"53","author":"Burkhoff","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.vph.2020.106810_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.vph.2020.106810_bb0050","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/cne.24455","article-title":"Localization, distribution, and connectivity of neuropeptide Y in the human and porcine retinas-a comparative study","volume":"526","author":"Christiansen","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.vph.2020.106810_bb0055","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1111\/bph.12751","article-title":"NPY\/Y(1) receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension","volume":"171","author":"Crnkovic","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0703162","article-title":"BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist","volume":"129","author":"Dumont","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vph.2015.04.011","article-title":"Role of l-type Ca2+ channels, sarcoplasmic reticulum and rho kinase in rat basilar artery contractile properties in a new model of subarachnoid hemorrhage","volume":"72","author":"Egea-Guerrero","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1113\/jphysiol.2003.058594","article-title":"Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle","volume":"556","author":"Fountain","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.vph.2020.106810_bb0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/sj.bjp.0703925","article-title":"Nerve evoked P2X receptor contractions of rat mesenteric arteries; dependence on vessel size and lack of role of L-type calcium channels and calcium induced calcium release","volume":"132","author":"Gitterman","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2006.03.080","article-title":"Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from the early non-obese diabetic mouse","volume":"539","author":"Gradin","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0085","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"NC-IUPHAR, the IUPHAR\/BPS guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vph.2020.106810_bb0090","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/STROKEAHA.114.005544","article-title":"ATP-evoked sustained vasoconstrictions mediated by heteromeric P2X1\/4 receptors in cerebral arteries","volume":"45","author":"Harhun","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2020.106810_bb0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1476-5381.2010.00714.x","article-title":"Purinoreceptor-mediated current in myocytes from renal resistance arteries","volume":"160","author":"Harhun","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.bjp.0706004","article-title":"Novel role for P2X receptor activation in endothelium-dependent vasodilation","volume":"143","author":"Harrington","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.118.11498","article-title":"DPP (dipeptidyl peptidase)-4 inhibition potentiates the vasoconstrictor response to NPY (neuropeptide Y) in humans during renin-angiotensin-aldosterone system inhibition","volume":"72","author":"Hubers","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2020.106810_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01761-8","article-title":"NF449, a novel picomolar potency antagonist at human P2X1 receptors","volume":"470","author":"Hulsmann","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/24.2.102","article-title":"Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure","volume":"24","author":"Hulting","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2020.106810_bb0120","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.168955","article-title":"P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet","volume":"57","author":"Inscho","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2020.106810_bb0125","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1172\/JCI18499","article-title":"Physiological role for P2X1 receptors in renal microvascular autoregulatory behaviour","volume":"112","author":"Inscho","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2020.106810_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.autneu.2015.04.004","article-title":"ATP as a cotransmitter in the autonomic nervous system","volume":"191","author":"Kennedy","year":"2015","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.vph.2020.106810_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(86)90409-7","article-title":"The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation","volume":"122","author":"Kennedy","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.vph.2020.106810_bb0145","doi-asserted-by":"crossref","first-page":"H3106","DOI":"10.1152\/ajpheart.00466.2006","article-title":"P2X1 receptors mediate sympathetic postjunctional Ca2+ transients in mesenteric small arteries","volume":"291","author":"Lamont","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2020.106810_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.apsb.2012.04.005","article-title":"P2X1 receptor-mediated pressor responses in the anesthetized mouse","volume":"2","author":"Li","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.vph.2020.106810_bb0155","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1016\/S0021-9258(17)37183-1","article-title":"A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line","volume":"269","author":"Lynch","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2020.106810_bb0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bjp.0701154","article-title":"The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo","volume":"121","author":"Malmstrom","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1748-1716.1995.tb09981.x","article-title":"Endogenous NPY acting on the Y1 receptor accounts for the long-lasting part of the sympathetic contraction in Guinea-pig vena cava: evidence using SR 120107A","volume":"155","author":"Malmstrom","year":"1995","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.vph.2020.106810_bb0170","first-page":"C1290","article-title":"Neuropeptide Y inhibition of calcium channels in PC-12 pheochromocytoma cells","volume":"274","author":"McCullough","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.vph.2020.106810_bb0175","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1523\/JNEUROSCI.16-04-01422.1996","article-title":"Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells","volume":"16","author":"McQuiston","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.vph.2020.106810_bb0180","first-page":"H1727","article-title":"Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes","volume":"261","author":"Millar","year":"1991","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.vph.2020.106810_bb0185","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.270.50.30102","article-title":"Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors","volume":"270","author":"Nakamura","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2020.106810_bb0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2020.106810_bb0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1139\/Y08-054","article-title":"Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth","volume":"86","author":"Pons","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0200","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/sj.bjp.0703256","article-title":"Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y1-receptor in rat mesenteric small arteries","volume":"129","author":"Prieto","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1085\/jgp.200208730","article-title":"Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations","volume":"121","author":"Rettinger","year":"2003","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.vph.2020.106810_bb0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1471-4159.1991.tb02001.x","article-title":"Neuropeptide Y receptor in vascular smooth muscle","volume":"56","author":"Shigeri","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.vph.2020.106810_bb0215","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/oxfordjournals.jbchem.a124938","article-title":"Neuropeptide YY1 receptors-mediated increase in intracellular Ca2+ concentration via phospholipase C-dependent pathway in porcine aortic smooth muscle cells","volume":"118","author":"Shigeri","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.vph.2020.106810_bb0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0028-3908(02)00382-9","article-title":"Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus","volume":"44","author":"Silva","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.vph.2020.106810_bb0225","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2020.106810_bb0230","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0735-1097(97)82759-3","article-title":"Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs","volume":"29","author":"Tanaka","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2020.106810_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-201X.2003.01057.x","article-title":"Transmitter characteristics of cutaneous, renal and skeletal muscle small arteries in the rat","volume":"177","author":"Tarasova","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.vph.2020.106810_bb0240","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1124\/mol.62.6.1438","article-title":"P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries","volume":"62","author":"Vial","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0245","doi-asserted-by":"crossref","DOI":"10.1124\/mol.118.112441","article-title":"Molecular Determinants of the Differential Modulation of Cav1.2 and Cav1.3 by Nifedipine and FPL 64176","volume":"94","author":"Wang","year":"2018","journal-title":"Mol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2020.106810_bb0250","first-page":"75S","article-title":"Neuropeptides in hypertension: role of neuropeptide Y and calcitonin gene related peptide","volume":"30","author":"Westfall","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0702084","article-title":"Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents","volume":"125","author":"Wieland","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2020.106810_bb0260","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2005.08.023","article-title":"Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension","volume":"44","author":"Wiest","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.vph.2020.106810_bb0265","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1152\/jn.1990.63.6.1499","article-title":"Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism","volume":"63","author":"Wiley","year":"1990","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.vph.2020.106810_bb0270","doi-asserted-by":"crossref","DOI":"10.1007\/BF00374948","article-title":"Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells","volume":"423","author":"Xiong","year":"1993","journal-title":"Pflugers. Arch."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189120303153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189120303153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:19:40Z","timestamp":1761527980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189120303153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":54,"alternative-id":["S1537189120303153"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2020.106810","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2020.106810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106810"}}